Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

APO Medical Opportunities

+ Add to Watchlist

APOMOPP:LX

120.09 EUR 0.39 0.33%

As of 00:59:30 ET on 01/30/2015.

Snapshot for APO Medical Opportunities (APOMOPP)

Year To Date: +3.82% 3-Month: +7.25% 3-Year: +22.59% 52-Week Range: 98.91 - 121.06
1-Month: +3.82% 1-Year: +19.04% 5-Year: +16.49% Beta vs LUXXX: 0.60

Mutual Fund Chart for APOMOPP

No chart data available.
  • APOMOPP:LX 120.09
  • 1M
  • 1Y
Interactive APOMOPP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for APOMOPP

APO Medical Opportunities is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equities of companies from the health care sector.

Inception Date: 08-31-2005 Telephone: 352-260248-1 Tel
Managers: KAI BRUENING / HARALD SCHWARZ
Web Site: www.ipconcept.lu

Fundamentals for APOMOPP

NAV (on 2015-01-30) 120.09
Assets (M) (on 2015-01-30) 178.58
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for APOMOPP

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for APOMOPP

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 0.57
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.96

Top Fund Holdings for APOMOPP

Filing Date: 12/31/2014
Name Position Value % of Total
Novartis AG 67,178 5,159,371 3.020%
Roche Holding AG 21,768 4,886,027 2.860%
Amgen Inc 35,558 4,681,019 2.740%
AbbVie Inc 81,474 4,373,507 2.560%
Abbott Laboratories 111,245 4,117,246 2.410%
Bayer AG 33,563 3,792,650 2.220%
BioMarin Pharmaceutical Inc 47,563 3,553,474 2.080%
Sanofi 46,741 3,536,390 2.070%
H Lundbeck A/S 199,932 3,297,214 1.930%
Edwards Lifesciences Corp 29,373 3,092,206 1.810%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil